Electronic Nicotine-Delivery Systems for Smoking Cessation

Authors:
  • ASAnna Schoeni
    Anna Schoeni
  • JHJean-Paul Humair
    Jean-Paul Humair
  • IJIsabelle Jacot-Sadowski
    Isabelle Jacot-Sadowski
  • IBIvan Berlin
    Ivan Berlin
  • MSMirah J. Stuber
    Mirah J. Stuber
  • MHMoa Lina Haller
    Moa Lina Haller
  • RTRodrigo Casagrande Tango
    Rodrigo Casagrande Tango
  • AFAnja Frei
    Anja Frei
  • ASAlexandra Strassmann
    Alexandra Strassmann
  • PBPhilip Bruggmann
    Philip Bruggmann
  • FBFlorent Baty
    Florent Baty

Abstract
Electronic nicotine-delivery systems - also called e-cigarettes - are used by some tobacco smokers to assist with quitting. Evidence regarding the efficacy and safety of these systems is needed. In this open-label, controlled trial, we randomly assigned adults who were smoking at least five tobacco cigarettes per day and who wanted to set a quit date to an intervention group, which received free e-cigarettes and e-liquids, standard-of-care smoking-cessation counseling, and optional (not free) nicotine-replacement therapy, or to a control group, which received standard counseling and a voucher, which they could use for any purpose, including nicotine-replacement therapy. The primary outcome was biochemically validated, continuous abstinence from smoking at 6 months. Secondary outcomes included participant-reported abstinence from tobacco and from any nicotine (including smoking, e-cigarettes, and nicotine-replacement therapy) at 6 months, respiratory symptoms, and serious adverse events. A total of 1246 participants underwent randomization; 622 participants were assigned to the intervention group, and 624 to the control group. The percentage of participants with validated continuous abstinence from tobacco smoking was 28.9% in the intervention group and 16.3% in the control group (relative risk, 1.77; 95% confidence interval, 1.43 to 2.20). The percentage of participants who abstained from smoking in the 7 days before the 6-month visit was 59.6% in the intervention group and 38.5% in the control group, but the percentage who abstained from any nicotine use was 20.1% in the intervention group and 33.7% in the control group. Serious adverse events occurred in 25 participants (4.0%) in the intervention group and in 31 (5.0%) in the control group; adverse events occurred in 272 participants (43.7%) and 229 participants (36.7%), respectively. The addition of e-cigarettes to standard smoking-cessation counseling resulted in greater abstinence from tobacco use among smokers than smoking-cessation counseling alone. (Funded by the Swiss National Science Foundation and others; ESTxENDS ClinicalTrials.gov number, NCT03589989.).
Funding Information
  • Swiss Tobacco Prevention Fund (19.017477)
  • Lunge Zürich (NA)
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (33IC30_173552)
  • Swiss Cancer Research Foundation (KFS4744-02-2019)

This publication has 22 references indexed in Scilit: